Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Percutaneous valve procedures: what is the future?

Alec Vahanian1, Christophe Acar

  • 1Bichat Hospital, Paris, France, Pitie-Salepetriere Hospital, Paris, France. cardio.sec1@bch.ap-hop-paris.fr

Current Opinion in Cardiology
|February 16, 2005
PubMed
Summary

Percutaneous valve interventions have evolved significantly, offering effective treatment for mitral stenosis while new techniques for aortic valve replacement and mitral valve repair show promise, particularly for high-risk patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Survival outcomes in isolated severe tricuspid regurgitation according to therapeutic modalities: a systematic review and meta-analysis.

Open heart·2025
Same author

Hospitalization of Symptomatic Patients With Heart Failure and Moderate to Severe Functional Mitral Regurgitation Treated With MitraClip: Insights From RESHAPE-HF2.

Journal of the American College of Cardiology·2024
Same author

Transcatheter Valve Repair in Heart Failure with Moderate to Severe Mitral Regurgitation.

The New England journal of medicine·2024
Same author

Sex-related differences in severe native valvular heart disease: the ESC-EORP Valvular Heart Disease II survey.

European heart journal·2024
Same author

Management of Massive Thrombosis of a Tendyne Valve: The Importance of Heart Valve Centers.

JACC. Case reports·2024
Same author

Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure: Baseline characteristics of patients in the RESHAPE-HF2 trial and comparison to COAPT and MITRA-FR trials.

European journal of heart failure·2024

Area of Science:

  • Interventional Cardiology
  • Valvular Heart Disease Management

Background:

  • Interventional cardiology has expanded beyond coronary artery disease to include peripheral, congenital, and valvular heart diseases.
  • Percutaneous mitral commissurotomy and aortic valvuloplasty have been performed since the mid-1980s.
  • Balloon commissurotomy is a well-established procedure for mitral stenosis, largely replacing surgical methods.

Purpose of the Study:

  • To review the evolution and current status of percutaneous interventions in valvular heart disease.
  • To highlight emerging percutaneous techniques for aortic and mitral valve diseases.
  • To assess the feasibility and potential of new percutaneous valve interventions.

Main Methods:

  • Review of historical and current percutaneous valvular interventions.

Related Experiment Videos

  • Evaluation of preliminary data on novel percutaneous valve replacement and repair techniques.

    • Main Results:

    • Percutaneous mitral commissurotomy demonstrates good short- and long-term results for mitral stenosis.
    • Percutaneous aortic valvuloplasty has seen limited success and is largely abandoned.
    • New percutaneous techniques for aortic valve replacement and mitral valve repair are in early stages but show feasibility.

    Conclusions:

    • Percutaneous interventions are crucial in managing valvular heart disease.
    • Emerging percutaneous valve technologies hold significant future potential, especially for high-risk individuals.
    • Further evaluation is needed to compare new percutaneous techniques with existing treatments.